vs
CoastalSouth Bancshares, Inc.(COSO)与SUTRO BIOPHARMA, INC.(STRO)财务数据对比。点击上方公司名可切换其他公司
CoastalSouth Bancshares, Inc.的季度营收约是SUTRO BIOPHARMA, INC.的1.8倍($21.3M vs $11.6M)
CoastalSouth Bancshares, Inc.是一家美国区域性银行控股企业,主要通过旗下附属银行开展业务,为美国墨西哥湾沿岸地区的零售客户与中小企业提供存款、消费贷款、商业融资、抵押贷款、财富管理等多元金融服务。
Sutro Biopharma是一家上市生物科技公司,总部位于加州南旧金山,专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台,结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology,2009年改用现名。
COSO vs STRO — 直观对比
营收规模更大
COSO
是对方的1.8倍
$11.6M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $21.3M | $11.6M |
| 净利润 | $6.7M | — |
| 毛利率 | — | — |
| 营业利润率 | 41.2% | — |
| 净利率 | 31.7% | — |
| 营收同比 | — | -21.4% |
| 净利润同比 | — | 35.4% |
| 每股收益(稀释后) | $0.54 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
COSO
STRO
| Q4 25 | — | $11.6M | ||
| Q3 25 | $21.3M | $9.7M | ||
| Q2 25 | $19.9M | $63.7M | ||
| Q1 25 | — | $17.4M | ||
| Q4 24 | — | $14.8M | ||
| Q3 24 | — | $8.5M | ||
| Q2 24 | — | $25.7M | ||
| Q1 24 | — | $13.0M |
净利润
COSO
STRO
| Q4 25 | — | — | ||
| Q3 25 | $6.7M | $-56.9M | ||
| Q2 25 | $6.0M | $-11.5M | ||
| Q1 25 | — | $-76.0M | ||
| Q4 24 | — | $-72.4M | ||
| Q3 24 | — | $-48.8M | ||
| Q2 24 | — | $-48.0M | ||
| Q1 24 | — | $-58.2M |
营业利润率
COSO
STRO
| Q4 25 | — | — | ||
| Q3 25 | 41.2% | -499.9% | ||
| Q2 25 | 35.4% | -5.2% | ||
| Q1 25 | — | -393.8% | ||
| Q4 24 | — | -440.7% | ||
| Q3 24 | — | -797.2% | ||
| Q2 24 | — | -189.4% | ||
| Q1 24 | — | -435.0% |
净利率
COSO
STRO
| Q4 25 | — | — | ||
| Q3 25 | 31.7% | -586.6% | ||
| Q2 25 | 30.0% | -18.0% | ||
| Q1 25 | — | -436.6% | ||
| Q4 24 | — | -489.2% | ||
| Q3 24 | — | -572.6% | ||
| Q2 24 | — | -186.8% | ||
| Q1 24 | — | -447.5% |
每股收益(稀释后)
COSO
STRO
| Q4 25 | — | — | ||
| Q3 25 | $0.54 | $-0.67 | ||
| Q2 25 | $0.57 | $-0.14 | ||
| Q1 25 | — | $-0.91 | ||
| Q4 24 | — | $-27.63 | ||
| Q3 24 | — | $-0.59 | ||
| Q2 24 | — | $-0.59 | ||
| Q1 24 | — | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $141.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $250.4M | $-132.5M |
| 总资产 | $2.3B | $173.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
COSO
STRO
| Q4 25 | — | $141.4M | ||
| Q3 25 | — | $167.6M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $249.0M | ||
| Q4 24 | — | $316.9M | ||
| Q3 24 | — | $388.3M | ||
| Q2 24 | — | $375.6M | ||
| Q1 24 | — | $267.6M |
股东权益
COSO
STRO
| Q4 25 | — | $-132.5M | ||
| Q3 25 | $250.4M | $-87.3M | ||
| Q2 25 | $209.4M | $-32.1M | ||
| Q1 25 | — | $-25.8M | ||
| Q4 24 | — | $44.6M | ||
| Q3 24 | — | $111.2M | ||
| Q2 24 | — | $152.2M | ||
| Q1 24 | — | $98.0M |
总资产
COSO
STRO
| Q4 25 | — | $173.8M | ||
| Q3 25 | $2.3B | $209.7M | ||
| Q2 25 | $2.2B | $262.4M | ||
| Q1 25 | — | $321.4M | ||
| Q4 24 | — | $387.2M | ||
| Q3 24 | — | $451.8M | ||
| Q2 24 | — | $489.0M | ||
| Q1 24 | — | $403.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-5.5M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $-5.9M | — |
| 自由现金流率自由现金流/营收 | -27.7% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | -0.82× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
COSO
STRO
| Q4 25 | — | $-177.2M | ||
| Q3 25 | $-5.5M | $-38.2M | ||
| Q2 25 | $-16.8M | $-44.7M | ||
| Q1 25 | — | $-67.9M | ||
| Q4 24 | — | $-71.7M | ||
| Q3 24 | — | $-64.5M | ||
| Q2 24 | — | $9.5M | ||
| Q1 24 | — | $-64.7M |
自由现金流
COSO
STRO
| Q4 25 | — | — | ||
| Q3 25 | $-5.9M | — | ||
| Q2 25 | $-17.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率
COSO
STRO
| Q4 25 | — | — | ||
| Q3 25 | -27.7% | — | ||
| Q2 25 | -90.3% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
COSO
STRO
| Q4 25 | — | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 5.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率
COSO
STRO
| Q4 25 | — | — | ||
| Q3 25 | -0.82× | — | ||
| Q2 25 | -2.82× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图